Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Circulating tumor DNA predicts outcome in metastatic gastroesophageal cancer.

Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association - 1 Sept 2022

van Velzen Merel J M, Creemers Aafke, van den Ende Tom, Schokker Sandor, Krausz Sarah, Reinten Roy J, Dijk Frederike, van Noesel Carel J M, Halfwerk Hans, Meijer Sybren L, Mearadji Banafsche, Derks Sarah, Bijlsma Maarten F, van Laarhoven Hanneke W M

Abstract excerpt

BACKGROUND: Circulating tumor DNA (ctDNA) has predictive and prognostic value in localized and metastatic cancer. This study analyzed the prognostic value of baseline and on-treatment ctDNA in metastatic gastroesophageal cancer (mGEC) using a region-specific next generation sequencing (NGS) panel. METHODS: Cell free DNA was isolated from plasma of patients before start of first-line palliative systemic treatment...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Circulating Tumor DNA
Share to Biomarkers, Tumor

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Esophageal Neoplasms

Share to Mutation

Share to Prognosis

Share to Stomach Neoplasms

Source

Open in PubMed Open full text

Identifiers

PMID: 35763187
DOI: 10.1007/s10120-022-01313-w
PMCID: PMC9365750

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Circulating tumor DNA predicts outcome in metastatic gastroesophageal cancer.PMID 35763187Read ↗

Circulating Tumor DNA Sequencing Analysis of Gastroesophageal AdenocarcinomaSemantic proximity Read ↗

Potential Clinical Utility of a Targeted Circulating Tumor DNA Assay in Esophageal Adenocarcinoma.Semantic proximity Read ↗

Development of circulating tumour DNA analysis for gastrointestinal cancersSemantic proximity Read ↗

ctDNA analysis in the personalized clinical management of gastroesophageal adenocarcinoma: turning hope into reality.Semantic proximity Read ↗

Serial ctDNA Monitoring to Predict Response to Systemic Therapy in Metastatic Gastrointestinal Cancers.Semantic proximity Read ↗

Genome-wide and panel-based cell-free DNA characterization of patients with resectable esophageal adenocarcinoma.Semantic proximity Read ↗

Prognostic Biomarkers and Immunotherapeutic Insights of Circulating Tumor DNA Analysis in Advanced Esophageal Squamous Cell Carcinoma From SCRUM-MONSTAR GOZILA Substudy.Semantic proximity Read ↗

Analysis of circulating tumor DNA to predict risk of recurrence in patients with esophageal and gastric cancersSemantic proximity Read ↗

Clinical value of preoperative circulating tumor DNA before surgery in patients with esophageal squamous cell carcinoma.Semantic proximity Read ↗

Frequent tumor burden monitoring of esophageal squamous cell carcinoma with circulating tumor DNA using individually designed digital PCRSemantic proximity Read ↗

Targeted Sequencing of Circulating Tumor DNA to Monitor Genetic Variants and Therapeutic Response in Metastatic Colorectal Cancer.Semantic proximity Read ↗

Circulating tumor DNA as an early marker of therapeutic response in patients with metastatic colorectal cancer.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.